Prognostic Value of CRP–Albumin–Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer
International Journal of General Medicine · 2024-03 · Volume 17 · 997-1005
DOI: 10.2147/ijgm.s447201 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of General Medicine, 2024-03. Verfasst von Jiaru Zhuang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Jiangnan University Medical Center, Wuxi, People's Republic of China. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
According to the 2023 global cancer data, breast cancer is the most common malignant tumor among women in the world. Its occurrence and development is influenced by inflammation, nutrition, and immune status. Therefore, this study combines C-reactive protein (CRP), albumin, and lymphocyte, which can reflect the above states, to form the CRP-albumin-lymphocyte (CALLY) index, an indicator to evaluate its relationship with overall survival (OS) and disease-free survival (DFS) in breast cancer patients. Patients and Methods: We retrospectively analyzed the clinical and follow-up data of 174 patients with breast cancer. The optimal cutoff for the preoperative CALLY index was identified by considering the area under the receiver operating characteristic curve; subsequently, the discriminatory ability of the cutoff was determined. The effect of the CALLY index on overall survival (OS) and disease-free survival (DFS) was analyzed using the Kaplan-Meier method and the Cox proportional hazards model. The CALLY index was calculated as: (Albumin × Lymphocyte)/(CRP × 104).
Results
The cut-off value of the CALLY index was determined at 2.285. With a cut-off value of 2.285, patients were divided into two groups: those with CALLY
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Jiangnan University Medical Center, Wuxi, People's Republic of China.
- Human Reproductive and Genetic Center, Affiliated Hospital of Jiangnan University, Wuxi, People's Republic of China.
ORCID-Profile: Renjing Hu
Zitieren
APA
Zhuang, J., Wang, S., Wang, Y., Wu, Y., & Hu, R. (2024). Prognostic Value of CRP–Albumin–Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer. International Journal of General Medicine, Volume 17, 997-1005. https://doi.org/10.2147/ijgm.s447201
Vancouver
Zhuang J, Wang S, Wang Y, Wu Y, Hu R. Prognostic Value of CRP–Albumin–Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer. International Journal of General Medicine. 2024;Volume 17:997-1005. doi:10.2147/ijgm.s447201
BibTeX
@article{Zhuang2024,
author = {Zhuang, Jiaru and Wang, Shan and Wang, Yuan and Wu, Yibo and Hu, Renjing},
title = {Prognostic Value of CRP–Albumin–Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer},
journal = {International Journal of General Medicine},
year = {2024},
volume = {Volume 17},
pages = {997--1005},
doi = {10.2147/ijgm.s447201}
}
EUVIMED